000 | 01202 a2200337 4500 | ||
---|---|---|---|
005 | 20250513175429.0 | ||
264 | 0 | _c19990520 | |
008 | 199905s 0 0 eng d | ||
022 | _a0140-6736 | ||
024 | 7 |
_a10.1016/s0140-6736(98)04835-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBaltzan, M A | |
245 | 0 | 0 |
_aHip fractures attributable to corticosteroid use. Study of Osteoporotic Fractures Group. _h[electronic resource] |
260 |
_bLancet (London, England) _cApr 1999 |
||
300 |
_a1327 p. _bdigital |
||
500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdministration, Inhalation |
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadministration & dosage |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aBone Density |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHip Fractures _xchemically induced |
650 | 0 | 4 | _aHumans |
700 | 1 | _aSuissa, S | |
700 | 1 | _aBauer, D C | |
700 | 1 | _aCummings, S R | |
773 | 0 |
_tLancet (London, England) _gvol. 353 _gno. 9161 _gp. 1327 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(98)04835-1 _zAvailable from publisher's website |
999 |
_c10177705 _d10177705 |